Biotechnology
BT 2750 | 2014
CELL LINE DEVELOPMENT MARKET [By Product (Equipment, Media and Reagents), By Source, By Type, By Application (Bioproduction, Tissue engineering & Regenerative Medicine, Toxicity Testing, Research, Drug Discovery)]
– ANALYSIS & GLOBAL FORECAST TO 2019 Report Description
Table of Contents List of Tables Sample Tables Related Reports
MarketsandMarkets North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas, TX 75252, U.S. Tel. No.: 1-888-600-6441 Email: sales@marketsandmarkets.com Website: www.marketsandmarkets.com
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers fourteen industry verticals, including aerospace and defence, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
Copyright Š 2014 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.
1 Š MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
1
INTRODUCTION
1.1
OBJECTIVES OF THE STUDY
BT 2750
To define and measure the global cell line development market on the basis of products, sources, types, applications, and geographies
To identify the key micromarkets1 and their drivers within the global cell line development market, which are expected to show impressive growth opportunities in the coming years
To identify market trends, gaps, and opportunities for all the stakeholders
To strategically analyze the market structure and profile the key players of the global cell line development market and comprehensively analyze their core competencies2
To track and analyze competitive developments such as partnerships, agreements and collaborations, expansions, acquisitions, and new product developments
1. Micromarkets are defined as the further segments and subsegments of the global cell line development market included in the report. 2. Core competencies of the companies are captured in terms of their key developments, SWOT analysis, and key strategies adopted by them to sustain their position in the market.
1.2
MARKETS COVERED
This research report categorizes the global cell line development market into the following segments:
FIGURE 1
CELL LINE DEVELOPMENT MARKET SEGMENTATION
Cell Line Development Market, by Product
Equipment Media and Reagents
Cell Line Development Market, by Source
Mammalian
Insect
Amphibian
Cell Line Development Market, by Type
Primary Cell Lines Continuous Cell Lines Hybridomas
Recombinant Cell Lines
Cell Line Development Market, by Application
Cell Line Development Market, by Geography
Bioproduction
North America
• Diagnostics • Vaccines • Recombinant Protein Therapeutics
• U.S. • Canada
Tissue Engineering & Regenerative Medicines Toxicity Testing
Europe • • • •
France Germany U.K. Rest of Europe(RoE)
Asia
RoW Research
Drug Discovery
Source: The World Bank, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), Pharmaceutical Research and Manufacturers of America (PhRMA), The US National Cancer Institute (NCI), National Institutes of Health (NIH), Cambridge Healthtech Institute, Baylor Institute for Immunology Research (BIIR), Institute of Stem cell Biology and Regenerative Medicine, The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)Expert Interviews, and MarketsandMarkets Analysis
2 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
Global Cell Line Development Market, by Product
Equipment
Biosafety Cabinets
Cell Counters and Viability Systems
Incubators
Centrifuges
Bioreactors
Storage Equipment
Cell Culture Refrigerators and Freezers
Cell Culture Cryogenic Storage
Automated Systems
Microscopes
Filtration Systems
Others
Media and Reagents
Sera
Fetal Bovine Sera
Adult Bovine Sera
Other Animal Sera
Media
Minimum Essential Media
Reduced Serum Media
Serum-free Media
Reagents
Supplements and Growth Factors
Buffers and Chemicals
Cell Dissociation Reagents
Cryopreservative Reagents
Others
Global Cell Line Development Market, by Source
Mammalian
Insect
Amphibian
3 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
Global Cell Line Development Market, by Type
Primary Cell Lines
Continuous Cell Lines
Hybridomas
Recombinant Cell Lines
Cell Line Development Market, by Application
Bioproduction
Diagnostics
Vaccines
Recombinant Protein Therapeutics
Tissue Engineering & Regenerative Medicines
Toxicity Testing
Research
Drug Discovery
Cell Line Development Market, by Geography
North America
U.S
Canada
Europe
France
Germany
U.K.
Rest of Europe
Asia
Rest of the World (RoW)
1.3
STAKEHOLDERS
Manufacturing companies of cell lines and cell line development equipment, media, reagents, and related products
Suppliers and distributors of cell lines and cell line development equipment, media, and reagents
Research institutes and academic centers
Pharmaceutical and biopharmaceutical companies
Biotechnology companies
Molecular diagnostic companies
Business research and consulting service providers
Venture capitalists 4
© MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
2
BT 2750
RESEARCH METHODOLOGY
FIGURE 2
GLOBAL CELL LINE DEVELOPMENT : RESEARCH METHODOLOGY STEPS
• Market classification for the overall cell line development market • Technical information on cell line development market by product, source, type, application, and geography
Secondary Research
• Available solutions in the market • Key players in the cell line development market • Technological developments • Annual Reports, SEC Filings/Investor Presentations, Press Releases of the key industry players
• Cell line development market size • Validation of market drivers, restraints, challenges, and opportunities
Primary Research
• Geographical markets with their market shares • Market trends and forecast • Value validation • Cell line development market segmentation • Top-down approach • Bottom-up approach
Market Crackdown
• Data triangulation • Market estimation • Market forecast • Qualitative and quantitative analysis
Source: MarketsandMarkets Analysis
5 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
TABLE OF CONTENTS 1
2
INTRODUCTION ........................................................................................................ 20 1.1
OBJECTIVES OF THE STUDY ...........................................................................................................20
1.2
MARKETS COVERED .....................................................................................................................20
1.3
STAKEHOLDERS ...........................................................................................................................22
RESEARCH METHODOLOGY ...................................................................................... 23 2.1.1
SECONDARY AND PRIMARY RESEARCH METHODOLOGY.................................................. 24 2.1.1.1
2.1.2
Secondary Research .......................................................................................... 24
KEY DATA FROM SECONDARY SOURCES ......................................................................... 24 2.1.2.1
Primary Research .............................................................................................. 25
2.1.2.2
Key Industry Insights.......................................................................................... 26
2.1.3
KEY DATA FROM PRIMARY SOURCES .............................................................................. 27
2.1.4
KEY INSIGHTS FROM PRIMARY SOURCES ....................................................................... 28
2.1.5
MARKET SIZE ESTIMATION METHODOLOGY ..................................................................... 28
2.1.6
MARKET FORECAST METHODOLOGY ............................................................................... 30
2.1.7
MARKET DATA VALIDATION AND DATA TRIANGULATION ................................................... 30
2.1.8
ASSUMPTIONS............................................................................................................... 31
2.1.9
LIMITATIONS .................................................................................................................. 32
3
EXECUTIVE SUMMARY .............................................................................................. 33
4
PREMIUM INSIGHTS ................................................................................................ 37
5
4.1
GLOBAL CELL LINE DEVELOPMENT MARKET SIZE ..........................................................................37
4.2
CELL LINE DEVELOPMENT MARKET, BY GEOGRAPHY AND TYPE ......................................................38
4.3
GEOGRAPHICAL SNAPSHOT ..........................................................................................................39
4.4
MARKET SHARE, BY PRODUCT ......................................................................................................39
4.5
LIFE CYCLE ANALYSIS, BY GEOGRAPHY .........................................................................................40
MARKET OVERVIEW.................................................................................................. 41 5.1
INTRODUCTION ............................................................................................................................42
5.2
MARKET DYNAMICS......................................................................................................................42 5.2.1
5.2.2
DRIVERS ........................................................................................................................ 43 5.2.1.1
Global Increase in Demand for Monoclonal Antibodies ....................................... 43
5.2.1.2
Innovative Technologies Accelerating the Scale-Up of Cell Lines ......................... 43
5.2.1.3
Rise in Vaccine Production ................................................................................ 44
CHALLENGE ................................................................................................................... 45 5.2.2.1
5.2.3
Developing Stable and Authentic Cell Lines........................................................ 45
OPPORTUNITIES ............................................................................................................. 46 5.2.3.1
Increasing Risk of Pandemics and Communicable Diseases ............................... 46 6
© MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
5.2.3.2
6
Low Income Countries to Create Opportunities for the Cell Line Development Market ......................................................................................... 46
INDUSTRY INSIGHTS ................................................................................................ 48 6.1
INTRODUCTION ............................................................................................................................48
6.2
COMPETITIVE POSITIONING, BY KEY PLAYER (2014) ......................................................................48
6.3
6.4
6.2.1
INTRODUCTION .............................................................................................................. 48
6.2.2
KEY HIGHLIGHTS ............................................................................................................ 50
CELL LINE DEVELOPMENT MARKET: EMPERICAL ASSESSMENT OF GROWTH STRATEGIES .................................................................................................................................52 6.3.1
ROUTE TO STRATEGIC GROWTH: ORGANIC OR INORGANIC GROWTH ................................ 52
6.3.2
ORGANIC GROWTH STRATEGIES ..................................................................................... 53
6.3.3
INORGANIC GROWTH STRATEGIES .................................................................................. 54
TECHNOLOGY ASSESSMENT .........................................................................................................55 6.4.1
7
BT 2750
EXPRESSION SYSTEMS .................................................................................................. 56 6.4.1.1
Methotrexate Amplification (DHFR) Technology .................................................. 57
6.4.1.2
Glutamine Synthatase (GS) Technology .............................................................. 57
6.4.1.3
Viral-Based Technology ..................................................................................... 57
GLOBAL CELL LINE DEVELOPMENT MARKET, BY PRODUCT ........................................ 59 7.1
CELL LINE DEVELOPMENT MARKET, BY PRODUCT ..........................................................................60
7.2
GLOBAL CELL LINE DEVELOPMENT MARKET, BY EQUIPMENT .........................................................61
7.3
7.2.1
INTRODUCTION .............................................................................................................. 61
7.2.2
BIOSAFETY CABINETS ..................................................................................................... 63
7.2.3
CELL COUNTERS & VIABILITY ANALYSIS SYSTEMS ........................................................... 64
7.2.4
INCUBATORS ................................................................................................................. 65
7.2.5
CENTRIFUGES ................................................................................................................ 66
7.2.6
BIOREACTORS ............................................................................................................... 67
7.2.7
STORAGE EQUIPMENT .................................................................................................... 68 Refrigerators & Freezers .................................................................................... 69
7.2.7.2
Cryostorage Systems ......................................................................................... 70
7.2.8
AUTOMATION SYSTEMS .................................................................................................. 71
7.2.9
MICROSCOPES .............................................................................................................. 72
7.2.10
FILTRATION SYSTEMS ..................................................................................................... 73
7.2.11
OTHER EQUIPMENT ........................................................................................................ 74
GLOBAL CELL LINE DEVELOPMENT MARKET, BY MEDIA & REAGENTS.............................................76 7.3.1
7.4
7.2.7.1
INTRODUCTION .............................................................................................................. 76
CELL LINE MEDIA & REAGENTS .....................................................................................................78 7.4.1
SERA ............................................................................................................................. 78 7.4.1.1
Fetal Bovine Sera (FBS) ..................................................................................... 81
7.4.1.2
Adult Bovine Sera (ABS) .................................................................................... 82
7.4.1.3
Other Animal Sera ............................................................................................. 82
7 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
7.4.2
7.4.3
8
MEDIA ........................................................................................................................... 83 7.4.2.1
Minimum Essential Media (MEM) ...................................................................... 85
7.4.2.2
Reduced Serum Media ...................................................................................... 86
7.4.2.3
Serum-Free Media (SFM) ................................................................................... 87
REAGENTS ..................................................................................................................... 88 7.4.3.1
Supplements & Growth Factors.......................................................................... 90
7.4.3.2
Buffers & Chemicals .......................................................................................... 91
7.4.3.3
Cell Dissociation Reagents ................................................................................ 92
7.4.3.4
Cryopreservative Reagents................................................................................. 93
7.4.3.5
Other Reagents ................................................................................................. 94
CELL LINE DEVELOPMENT MARKET, BY SOURCE ....................................................... 95 8.2
9
BT 2750
INTRODUCTION ............................................................................................................................96 8.2.1
MAMMALIAN.................................................................................................................. 97
8.2.2
INSECT........................................................................................................................... 98
8.2.3
AMPHIBIAN..................................................................................................................100
CELL LINE DEVELOPMENT MARKET, BY TYPE ........................................................... 101 9.1
INTRODUCTION ..........................................................................................................................102 9.1.1
PRIMARY CELL LINES ...................................................................................................103
9.1.2
CONTINUOUS CELL LINES .............................................................................................104
9.1.3
HYBRIDOMAS ..............................................................................................................105
9.1.4
RECOMBINANT CELL LINES ..........................................................................................107
10 GLOBAL CELL LINE DEVELOPMENT MARKET, BY APPLICATION................................. 109 10.2
INTRODUCTION ..........................................................................................................................110
10.3
BIOPRODUCTION........................................................................................................................113 10.3.1
DIAGNOSTICS ..............................................................................................................114
10.3.2
VACCINE PRODUCTION.................................................................................................115
10.3.3
RECOMBINANT PROTEIN THERAPEUTICS ......................................................................116
10.4
TISSUE ENGINEERING & REGENERATIVE MEDICINE.....................................................................117
10.5
TOXICITY TESTING .......................................................................................................................117
10.6
RESEARCH .................................................................................................................................118
10.7
DRUG DISCOVERY ......................................................................................................................119 10.7.1
TARGET VALIDATION .....................................................................................................119
10.7.2
DISEASE MODELING ....................................................................................................119
10.7.3
DRUG SCREENING AND DEVELOPMENT ........................................................................120
11 CELL LINE DEVELOPMENT MARKET, BY GEOGRAPHY ............................................... 121 11.1
INTRODUCTION ..........................................................................................................................122
11.2
NORTH AMERICA ........................................................................................................................124 11.2.1
U.S. .............................................................................................................................128
8 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
11.2.2
11.2.1.1
R&D Investments by Pharmaceutical Companies in the U.S. to Propel the Cell Line Development Market....................................................................128
11.2.1.2
Rise in Funding for Vaccine Production likely to Fuel Demand of Cell Line Development Market ................................................................................130
11.2.1.3
Conferences on Cell Line Development to Propel Growth of Market ...................130
CANADA.......................................................................................................................130 11.2.2.1
11.3
11.3.1
FLOURISHING VACCINE MARKET IN EUROPE—A MAJOR PROPELLANT FOR THE CELL LINE DEVELOPMENT MARKET ...............................................................................134
11.3.2
FRANCE .......................................................................................................................137
11.3.3
11.3.4
Advances in Biotechnology Fueling the Cell Line Development Market in Germany......................................................................................................139
U.K. .............................................................................................................................141 11.3.4.1
11.3.5
Increasing Use of Cell Lines for Vaccine Production to Spur Market in France.............................................................................................................137
GERMANY ....................................................................................................................139 11.3.3.1
Conferences on Cell Line Development to Spur Market in the U.K......................141
REST OF EUROPE (ROE) ................................................................................................143 11.3.5.1
Increasing Research on Regenerative Medicines in Spain to Propel the Cell Line Development Market....................................................................143
ASIA...........................................................................................................................................146 11.4.1
INDIA ...........................................................................................................................146 11.4.1.1
11.4.2 11.4.3
11.4.4
Growing Pharmaceutical Industry to Propel the Market in India .........................146
CHINA ..........................................................................................................................147 11.4.2.1
11.5
Increasing Investments on Regenerative Medicines by Canadian Government to Spur the Market .......................................................................130
EUROPE .....................................................................................................................................133
11.3.2.1
11.4
BT 2750
Developing Pharmaceutical Industry to Spur the Market in China ......................147
JAPAN ..........................................................................................................................147 11.4.3.1
Rise in Production of Vaccines in Japan to Propel the Use of Cell Lines ...............................................................................................................147
11.4.3.2
Regenerative Medicine, Biomedical, and Medical Research in Japan is on the Rise...................................................................................................147
REST OF ASIA (ROA) .....................................................................................................148 11.4.4.1
Initiation of Measles-Rubella Combined Vaccine Production in Vietnam ..........................................................................................................148
11.4.4.2
Government-Supported Strong Academic and Commercial R&D Activities in Taiwan ..........................................................................................148
REST OF THE WORLD (ROW) ........................................................................................................152 11.5.1
11.5.2
PACIFIC COUNTRIES .....................................................................................................153 11.5.1.1
Federal Collaborations in Australia to Bolster the Demand of Cell Lines ...............................................................................................................153
11.5.1.2
Favorable Regulatory Changes to Drive the Market in New Zealand and Australia...................................................................................................153
BRAZIL .........................................................................................................................153 11.5.2.1
Flourishing Biotechnology and Pharmaceutical Markets in Brazil to Bolster the Cell Line Development Market ........................................................153 9
© MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
11.5.3
BT 2750
AFRICA ........................................................................................................................154 11.5.3.1
Increasing Focus on Africa by Pharmaceutical Companies Likely to Create Avenues for Cell Line Development Market ............................................154
12 COMPETITIVE LANDSCAPE ..................................................................................... 158 12.1
OVERVIEW ..................................................................................................................................158
12.2
MARKET SHARE ANALYSIS, CELL LINE DEVELOPMENT MARKET ...................................................159 12.2.1
12.3
INTRODUCTION ............................................................................................................159 12.2.1.1
American Type Culture Collection (ATCC) (U.S.) ................................................159
12.2.1.2
Lonza Group AG (Switzerland) ..........................................................................160
12.2.1.3
Thermo Fisher Scientific, Inc. (U.S.) ..................................................................160
COMPETITIVE SITUATION AND TRENDS........................................................................................161 12.3.1
AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS ...............................................163
12.3.2
NEW PRODUCT LAUNCHES ...........................................................................................165
12.3.3
EXPANSIONS................................................................................................................166
12.3.4
ACQUISITIONS .............................................................................................................167
12.3.5
OTHERS .......................................................................................................................168
13 COMPANY PROFILES .............................................................................................. 169 13.1
INTRODUCTION ..........................................................................................................................169
13.2
AMERICAN TYPE CULTURE COLLECTION (ATCC) ...........................................................................170
13.3
CORNING, INC. ...........................................................................................................................174
13.4
EUROPEAN COLLECTION OF CELL CULTURES (ECACC) .................................................................178
13.5
GE HEALTHCARE .........................................................................................................................180
13.6
LONZA GROUP AG ......................................................................................................................184
13.7
SARTORIUS AG ...........................................................................................................................189
13.8
SELEXIS SA ................................................................................................................................192
13.9
SIGMA-ALDRICH CORPORATION .................................................................................................196
13.10
THERMO FISHER SCIENTIFIC, INC. ..............................................................................................202
13.11
WUXI APPTEC .............................................................................................................................207
*Details On Business Overview, Product Portfolio, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX .............................................................................................................. 209 14.1
DISCUSSION GUIDE ...................................................................................................................209
14.2
INTRODUCING RT: REAL TIME MARKET INTELLIGENCE .................................................................212
14.3
AVAILABLE CUSTOMIZATIONS .....................................................................................................213
14.4
RELATED REPORTS .....................................................................................................................214
10 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
LIST OF TABLES TABLE 1
DRIVERS PROPELLING THE GROWTH OF THE CELL LINE DEVELOPMENT MARKET
45
TABLE 2
MAJOR CHALLENGE IN THE CELL LINE DEVELOPMENT MARKET
46
TABLE 3
MAJOR GROWTH OPPORTUNITIES IN THE CELL LINE DEVELOPMENT MARKET
47
TABLE 4
CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
60
TABLE 5
CELL LINE DEVELOPMENT MARKET SIZE FOR EQUIPMENT, BY REGION, 2012– 2019 ($MILLION)
61
TABLE 6
CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2012–2019 ($MILLION)
62
TABLE 7
CELL LINE DEVELOPMENT MARKET SIZE FOR BIOSAFETY CABINETS, BY REGION, 2012–2019 ($MILLION)
64
CELL LINE DEVELOPMENT MARKET SIZE FOR CELL COUNTERS & VIABILITY ANALYSIS SYSTEMS, BY REGION, 2012–2019 ($MILLION)
65
CELL LINE DEVELOPMENT MARKET SIZE FOR INCUBATORS, BY REGION, 2012– 2019 ($MILLION)
66
CELL LINE DEVELOPMENT MARKET SIZE FOR CENTRIFUGES, BY REGION, 2012– 2019 ($MILLION)
66
CELL LINE DEVELOPMENT MARKET SIZE FOR BIOREACTORS, BY REGION, 2012– 2019 ($MILLION)
67
CELL LINE DEVELOPMENT MARKET SIZE FOR STORAGE EQUIPMENT, BY REGION, 2012–2019 ($MILLION)
68
CELL LINE DEVELOPMENT MARKET SIZE FOR STORAGE EQUIPMENT, BY SEGMENT, 2012–2019 ($MILLION)
68
CELL LINE DEVELOPMENT MARKET SIZE FOR REFRIGERATORS & FREEZERS, BY REGION, 2012–2019 ($MILLION)
70
CELL LINE DEVELOPMENT MARKET SIZE FOR CRYOSTORAGE SYSTEMS, BY REGION, 2012–2019 ($MILLION)
71
CELL LINE DEVELOPMENT MARKET SIZE FOR AUTOMATION SYSTEMS, BY REGION, 2012–2019 ($MILLION)
72
CELL LINE DEVELOPMENT MARKET SIZE FOR MICROSCOPES, BY REGION, 2012– 2019 ($MILLION)
73
CELL LINE DEVELOPMENT MARKET SIZE FOR FILTRATION SYSTEMS, BY REGION, 2012–2019 ($MILLION)
74
CELL LINE DEVELOPMENT MARKET SIZE FOR OTHER EQUIPMENT, BY REGION, 2012–2019 ($MILLION)
75
CELL LINE DEVELOPMENT MARKET SIZE FOR MEDIA & REAGENTS, BY SEGMENT, 2012–2019 ($MILLION)
76
CELL LINE DEVELOPMENT MARKET SIZE FOR MEDIA & REAGENTS, BY REGION, 2012–2019 ($MILLION)
77
CELL LINE DEVELOPMENT MARKET SIZE FOR SERA, BY REGION, 2012–2019 ($MILLION)
79
CELL LINE DEVELOPMENT MARKET SIZE FOR SERA, BY SEGMENT, 2012–2019 ($MILLION)
80
CELL LINE DEVELOPMENT MARKET SIZE FOR FETAL BOVINE SERA, BY REGION, 2012–2019 ($MILLION)
81
CELL LINE DEVELOPMENT MARKET SIZE FOR ADULT BOVINE SERA, BY REGION, 2012–2019 ($MILLION)
82
CELL LINE DEVELOPMENT MARKET SIZE FOR OTHER ANIMAL SERA, BY REGION, 2012–2019 ($MILLION)
83
TABLE 8 TABLE 9 TABLE 10 TABLE 11 TABLE 12 TABLE 13 TABLE 14 TABLE 15 TABLE 16 TABLE 17 TABLE 18 TABLE 19 TABLE 20 TABLE 21 TABLE 22 TABLE 23 TABLE 24 TABLE 25 TABLE 26
11 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
TABLE 27
BT 2750
CELL LINE DEVELOPMENT MARKET SIZE FOR MEDIA, BY REGION, 2012–2019 ($MILLION)
83
CELL LINE DEVELOPMENT MARKET SIZE FOR MEDIA, BY SEGMENT, 2012–2019 ($MILLION)
84
CELL LINE DEVELOPMENT MARKET SIZE FOR MINIMUM ESSENTIAL MEDIA, BY REGION, 2012–2019 ($MILLION)
86
CELL LINE DEVELOPMENT MARKET SIZE FOR REDUCED SERUM MEDIA, BY REGION, 2012–2019 ($MILLION)
87
CELL LINE DEVELOPMENT MARKET SIZE FOR SERUM-FREE MEDIA, BY REGION, 2012–2019 ($MILLION)
88
CELL LINE DEVELOPMENT MARKET SIZE FOR REAGENTS, BY REGION, 2012–2019 ($MILLION)
88
CELL LINE DEVELOPMENT MARKET SIZE FOR REAGENTS, BY SEGMENT, 2012– 2019 ($MILLION)
89
CELL LINE DEVELOPMENT MARKET SIZE FOR SUPPLEMENTS & GROWTH FACTORS, BY REGION, 2012–2019 ($MILLION)
91
CELL LINE DEVELOPMENT MARKET SIZE FOR BUFFERS & CHEMICALS, BY REGION, 2012–2019 ($MILLION)
92
CELL LINE DEVELOPMENT MARKET SIZE FOR CELL DISSOCIATION REAGENTS, BY REGION, 2012–2019 ($MILLION)
93
CELL LINE DEVELOPMENT MARKET SIZE FOR CRYOPRESERVATIVE REAGENTS, BY REGION, 2012–2019 ($MILLION)
93
CELL LINE DEVELOPMENT MARKET SIZE FOR OTHER REAGENTS, BY REGION, 2012–2019 ($MILLION)
94
TABLE 39
CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
96
TABLE 40
TYPES OF MAMMALIAN CELL LINES AND THEIR APPLICATIONS
97
TABLE 41
CELL LINE DEVELOPMENT MARKET SIZE FOR MAMMALIAN SOURCES, BY REGION, 2012–2019 ($MILLION)
98
CELL LINE DEVELOPMENT MARKET SIZE FOR INSECT SOURCES, BY REGION, 2012–2019 ($MILLION)
99
CELL LINE DEVELOPMENT MARKET SIZE FOR AMPHIBIAN SOURCES, BY REGION, 2012–2019 ($MILLION)
100
TABLE 44
CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
103
TABLE 45
CELL LINE DEVELOPMENT MARKET SIZE FOR PRIMARY CELL LINES, BY REGION, 2012–2019 ($MILLION)
103
CELL LINE DEVELOPMENT MARKET SIZE FOR CONTINUOUS CELL LINES, BY REGION, 2012–2019 ($MILLION)
104
CELL LINE DEVELOPMENT MARKET SIZE FOR HYBRIDOMAS, BY REGION, 2012– 2019 ($MILLION)
106
TABLE 48
BIOLOGICS PRODUCED USING CHO CELLS (2006-2012)
107
TABLE 49
CELL LINE DEVELOPMENT MARKET SIZE FOR RECOMBINANT CELL LINES, BY REGION, 2012–2019 ($MILLION)
108
CELL LINE DEVELOPMENT APPLICATIONS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
111
CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
112
CELL LINE DEVELOPMENT MARKET SIZE FOR BIOPRODUCTION, BY REGION, 2012–2019 ($MILLION)
113
CELL LINE DEVELOPMENT MARKET SIZE FOR BIOPRODUCTION, BY SEGMENT, 2012–2019 ($MILLION)
113
TABLE 28 TABLE 29 TABLE 30 TABLE 31 TABLE 32 TABLE 33 TABLE 34 TABLE 35 TABLE 36 TABLE 37 TABLE 38
TABLE 42 TABLE 43
TABLE 46 TABLE 47
TABLE 50 TABLE 51 TABLE 52 TABLE 53
12 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
TABLE 54
BT 2750
CELL LINE DEVELOPMENT MARKET SIZE FOR DIAGNOSTICS, BY REGION, 2012– 2019 ($MILLION)
115
CELL LINE DEVELOPMENT MARKET SIZE FOR VACCINE PRODUCTION, BY REGION, 2012–2019 ($MILLION)
116
CELL LINE DEVELOPMENT MARKET SIZE FOR RECOMBINANT PROTEIN THERAPEUTICS, BY REGION, 2012–2019 ($MILLION)
116
CELL LINE DEVELOPMENT MARKET SIZE FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2012–2019 ($MILLION)
117
CELL LINE DEVELOPMENT MARKET SIZE FOR TOXICITY TESTING, BY REGION, 2012–2019 ($MILLION)
118
CELL LINE DEVELOPMENT MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION, 2012–2019 ($MILLION)
118
CELL LINE DEVELOPMENT MARKET SIZE FOR DRUG DISCOVERY, BY REGION, 2012–2019 ($MILLION)
119
TABLE 61
CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
122
TABLE 62
NORTH AMERICA: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012– 2019 ($MILLION)
125
NORTH AMERICA: CELL LINE DEVELOPMENT EQUIPMENT MARKET SIZE, 2012– 2019 ($MILLION)
125
NORTH AMERICA: CELL LINE DEVELOPMENT MEDIA & REAGENTS MARKET SIZE, 2012–2019 ($MILLION)
125
NORTH AMERICA: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012– 2019 ($MILLION)
126
NORTH AMERICA: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
127
NORTH AMERICA: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
127
U.S.: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
128
U.S.: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
128
TABLE 70
U.S.: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
129
TABLE 71
U.S.: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
129
CANADA: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
131
CANADA: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
131
CANADA: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
132
CANADA: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
132
EUROPE: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
134
EUROPE: CELL LINE DEVELOPMENT EQUIPMENT MARKET SIZE, 2012–2019 ($MILLION)
135
EUROPE: CELL LINE DEVELOPMENT MEDIA & REAGENTS MARKET SIZE, 2012– 2019 ($MILLION)
135
EUROPE: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
136
TABLE 55 TABLE 56 TABLE 57 TABLE 58 TABLE 59 TABLE 60
TABLE 63 TABLE 64 TABLE 65 TABLE 66 TABLE 67 TABLE 68 TABLE 69
TABLE 72 TABLE 73 TABLE 74 TABLE 75 TABLE 76 TABLE 77 TABLE 78 TABLE 79
13 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
TABLE 80
BT 2750
EUROPE: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
136
EUROPE: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
137
FRANCE: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
137
FRANCE: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
138
FRANCE: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
138
FRANCE: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
139
GERMANY: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
139
GERMANY: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
140
GERMANY: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
140
GERMANY: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
141
U.K.: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
141
U.K.: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
142
TABLE 92
U.K.: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
142
TABLE 93
U.K.: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
143
ROE: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
144
ROE: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
144
TABLE 96
ROE: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
144
TABLE 97
ROE: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
145
ASIA: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
148
ASIA: CELL LINE DEVELOPMENT EQUIPMENT MARKET SIZE, 2012–2019 ($MILLION)
149
ASIA: CELL LINE DEVELOPMENT MEDIA & REAGENTS MARKET SIZE, 2012–2019 ($MILLION)
149
ASIA: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
150
TABLE 102
ASIA: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
150
TABLE 103
ASIA: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
151
ROW: CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)
154
ROW: CELL LINE DEVELOPMENT EQUIPMENT MARKET SIZE, 2012–2019 ($MILLION)
155
ROW: CELL LINE DEVELOPMENT MEDIA & REAGENTS MARKET SIZE, 2012–2019 ($MILLION)
155
TABLE 81 TABLE 82 TABLE 83 TABLE 84 TABLE 85 TABLE 86 TABLE 87 TABLE 88 TABLE 89 TABLE 90 TABLE 91
TABLE 94 TABLE 95
TABLE 98 TABLE 99 TABLE 100 TABLE 101
TABLE 104 TABLE 105 TABLE 106
14 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
TABLE 107
BT 2750
ROW: CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2012–2019 ($MILLION)
156
TABLE 108
ROW: CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
156
TABLE 109
ROW: CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2012–2019 ($MILLION)
157
TABLE 110
AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 2011–2014
164
TABLE 111
NEW PRODUCT LAUNCHES, 2011–2013
165
TABLE 112
EXPANSIONS, 2011–2014
166
TABLE 113
ACQUISITIONS, 2011–2014
167
TABLE 114
OTHERS, 2011–2014
168
15 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
LIST OF FIGURES FIGURE 1
CELL LINE DEVELOPMENT MARKET SEGMENTATION
20
FIGURE 2
GLOBAL CELL LINE DEVELOPMENT : RESEARCH METHODOLOGY STEPS
23
FIGURE 3
SAMPLING FRAME: PRIMARY RESEARCH
26
FIGURE 4
BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
27
FIGURE 5
MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
29
FIGURE 6
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
29
FIGURE 7
MARKET FORECAST METHODOLOGY
30
FIGURE 8
DATA TRIANGULATION METHODOLOGY
31
FIGURE 9
GLOBAL CELL LINE DEVELOPMENT MARKET SNAPSHOT, BY PRODUCT, 2014– 2019 33
FIGURE 10
MEDIA AND REAGENTS MARKET TO WITNESS HIGHEST CAGR OF 13% FROM 2014 TO 2019
34
FIGURE 11
GLOBAL CELL LINE DEVELOPMENT MARKET SHARE, 2014
35
FIGURE 12
CELL LINE DEVELOPMENT: MARKET OVERVIEW
37
FIGURE 13
NORTH AMERICA ACCOUNTS FOR LARGEST SHARE OF MARKET; RECOMBINANT CELL LINES ACCOUNTS FOR 70% OF MARKET, BY TYPE
38
ASIAN CELL LINE DEVELOPMENT MARKET TO GROW AT THE HIGHEST CAGR BETWEEN 2014 AND 2019
39
MEDIA AND REAGENTS TO COMMAND OVER 50% OF THE MARKET SHARE, 2014 VS. 2019
39
ROW IS EXPECTED TO ENTER THE EXPONENTIAL GROWTH PHASE IN THE COMING YEARS
40
INCREASING DEMAND FOR MONOCLONAL ANTIBODIES TO SPUR THE GROWTH IN THIS MARKET
42
FIGURE 18
COMPETITIVE POSITIONING, BY KEY PLAYER (2014)
49
FIGURE 19
COMPETITIVE POSITIONING, BY KEY PLAYER (2014)
50
FIGURE 20
ORGANIC AND INORGANIC GROWTH STRATEGIES
52
FIGURE 21
ORGANIC GROWTH STRATEGIES, BY KEY PLAYERS (2011–2014)
53
FIGURE 22
INORGANIC GROWTH STRATEGIES, BY KEY PLAYERS (2011–2014)
54
FIGURE 23
EVOLUTION OF CELL LINE DEVELOPMENT TECHNOLOGIES
55
FIGURE 24
COMPARATIVE TECHNOLOGY ASSESSMENT – CELL LINE DEVELOPMENT MARKET
56
FIGURE 25
THE MEDIA & REAGENTS SEGMENT IS EXPECTED TO GROW AT A FASTER PACE THAN THE EQUIPMENT SEGMENT FROM 2014 TO 2019
60
ASIA IS EXPECTED TO BE THE FASTEST-GROWING CELL LINE DEVELOPMENT MARKET AT A CAGR OF 14.8% FROM 2014 TO 2019
61
NORTH AMERICA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL LINE EQUIPMENT MARKET IN 2014
62
THE OTHER EQUIPMENT SEGMENT IS EXPECTED TO COMMAND THE LARGEST SHARE OF THE CELL LINE EQUIPMENT MARKET IN 2014
63
REFRIGERATORS & FREEZERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF 70% OF THE CELL LINE DEVELOPMENT MARKET FOR STORAGE EQUIPMENT IN 2014
69
THE REAGENTS SEGMENT IS EXPECTED TO DOMINATE THE CELL LINE DEVELOPMENT MARKET
77
FIGURE 14 FIGURE 15 FIGURE 16 FIGURE 17
FIGURE 26 FIGURE 27 FIGURE 28 FIGURE 29
FIGURE 30
16 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
FIGURE 31
BT 2750
ASIA IS THE FASTEST-GROWING REGIONAL SEGMENT OF THE CELL LINE DEVELOPMENT MARKET FOR MEDIA & REAGENTS
78
FIGURE 32
CELL LINE DEVELOPMENT MARKET FOR SERA, BY SEGMENT
79
FIGURE 33
THE FETAL BOVINE SERA SEGMENT IS EXPECTED TO COMMAND 60% OF THE CELL LINE DEVELOPMENT MARKET, GROWING AT THE HIGHEST CAGR OF 5.8%
80
FIGURE 34
CELL LINE DEVELOPMENT MARKET FOR MEDIA, BY SEGMENT
84
FIGURE 35
MINIMAL ESSENTIAL MEDIA TO GROW AT A HIGHER RATE FROM 2014 TO 2019
85
FIGURE 36
CELL LINE DEVELOPMENT MARKET FOR REAGENTS, BY SEGMENT
89
FIGURE 37
THE SUPPLEMENTS & GROWTH FACTORS SEGMENT IS EXPECTED TO ACCOUNT FOR MORE THAN 54% OF THE GLOBAL CELL LINE DEVELOPMENT MARKET, AND IS GROWING AT THE HIGHEST CAGR OF 13.3%
90
FIGURE 38
CELL LINE DEVELOPMENT MARKET, BY SOURCE
96
FIGURE 39
MAMMALIAN SEGMENT IS POISED TO DOUBLE IN SIZE BY 2019
97
FIGURE 40
WITH WIDE APPLICATION AREAS, MAMMALIAN SEGMENT HOLDS 75% OF THE MARKET IN 2014
99
FIGURE 41
CELL LINE DEVELOPMENT MARKET, BY TYPE
102
FIGURE 42
RECOMBINANT CELL LINES SEGMENT ACCOUNTS FOR 70% OF THE CELL LINE DEVELOPMENT MARKET, BY TYPE
102
HYBRIDOMAS IS THE FASTEST-GROWING SEGMENT OF THE CELL LINE DEVELOPMENT MARKET, BY TYPE
106
FIGURE 44
CELL LINE DEVELOPMENT APPLICATIONS MARKET, 2014–2019
110
FIGURE 45
ASIA IS THE FASTEST-GROWING REGION IN THE GLOBAL CELL LINE DEVELOPMENT APPLICATIONS MARKET
111
FIGURE 46
CELL LINE DEVELOPMENT MARKET, BY APPLICATION
112
FIGURE 47
RECOMBINANT PROTEIN THERAPEUTICS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF 60% AND IS GROWING AT THE HIGHEST CAGR OF 13.5%
114
NORTH AMERICA TO COMMAND LARGEST SHARE OF THE GLOBAL CELL LINE DEVELOPMENT MARKET
123
U.S.TO BE FASTEST-GROWING COUNTRY OF CELL LINE DEVELOPMENT MARKET IN NORTH AMERICA
124
GERMANY TO BE FASTEST-GROWING COUNTRY OF CELL LINE DEVELOPMENT MARKET IN EUROPE
133
FIGURE 51
ASIA IS THE FASTEST-GROWING CELL LINE DEVELOPMENT MARKET
146
FIGURE 52
ROW TO ACCOUNT FOR A 10% SHARE OF THE GLOBAL CELL LINE DEVELOPMENT MARKET
152
COMPANIES ADOPTED AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS AS THE KEY GROWTH STRATEGY OVER THE LAST THREE YEARS
158
FIGURE 54
MARKET SHARE ANALYSIS, BY KEY PLAYER, 2013
159
FIGURE 55
KEY GROWTH STRATEGIES OF THE GLOBAL CELL LINE DEVELOPMENT MARKET, 2011–2014
162
BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS WAS THE KEY STRATEGY
163
FIGURE 57
GEOGRAPHICAL REVENUE MIX OF TOP 5 MARKET PLAYERS
169
FIGURE 58
COMPANY SNAPSHOT
170
FIGURE 59
COMPANY SNAPSHOT
174
FIGURE 60
COMPANY SNAPSHOT
178
FIGURE 61
COMPANY SNAPSHOT
180
FIGURE 62
COMPANY SNAPSHOT
184
FIGURE 63
COMPANY SNAPSHOT
189
FIGURE 43
FIGURE 48 FIGURE 49 FIGURE 50
FIGURE 53
FIGURE 56
17 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
FIGURE 64
COMPANY SNAPSHOT
192
FIGURE 65
COMPANY SNAPSHOT
196
FIGURE 66
COMPANY SNAPSHOT
202
FIGURE 67
COMPANY SNAPSHOT
207
18 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
SAMPLE TABLES TABLE 1
CELL LINE DEVELOPMENT MARKET SIZE FOR BIOSAFETY CABINETS, BY REGION, 2012–2019 ($MILLION) Region
2012
2013
2014
CAGR%
2019
(2014–2019)
North America
XX
XX
XX
XX
XX
Europe
XX
XX
XX
XX
XX
Asia
XX
XX
XX
XX
XX
RoW
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: International Cell Line Authentication Committee (ICLAC), National Institute for Biological Standards and Control (NIBSC), World Health Organization (WHO), National Institutes of Health (NIH), Pharmaceutical Research and Manufacturers of America (PhRMA), US National Cancer Institute (NCI), Cambridge Healthtech Institute, Baylor Institute for Immunology Research (BIIR), Institute of Stem Cell Biology and Regenerative Medicine, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Expert Interviews, and MarketsandMarkets Analysis
TABLE 2
CELL LINE DEVELOPMENT MARKET SIZE FOR STORAGE EQUIPMENT, BY SEGMENT, 2012–2019 ($MILLION)
Segment
2012
2013
2014
CAGR%
2019
(2014–2019)
Refrigerators & Freezers
XX
XX
XX
XX
XX
Cryostorage Systems
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: International Cell Line Authentication Committee (ICLAC), National Institute for Biological Standards and Control (NIBSC), World Health Organization (WHO), National Institutes of Health (NIH), Pharmaceutical Research and Manufacturers of America (PhRMA), US National Cancer Institute (NCI), Cambridge Healthtech Institute, Baylor Institute for Immunology Research (BIIR), Institute of Stem Cell Biology and Regenerative Medicine, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Expert Interviews, and MarketsandMarkets Analysis
TABLE 3
CELL LINE DEVELOPMENT APPLICATIONS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) Region
2012
2013
2014
CAGR% (2014–2019)
2019
North America
XX
XX
XX
XX
XX
Europe
XX
XX
XX
XX
XX
Asia
XX
XX
XX
XX
XX
RoW
XX
XX
XX
XX
XX
Total
XX
XX
XX
XX
XX
Source: International Cell Line Authentication Committee (ICLAC), National Institute for Biological Standards and Control (NIBSC), World Health Organization (WHO), National Institutes of Health (NIH), Pharmaceutical Research and Manufacturers of America (PhRMA), US National Cancer Institute (NCI), Cambridge Healthtech Institute, Baylor Institute for Immunology Research (BIIR), Institute of Stem Cell Biology and Regenerative Medicine, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Expert Interviews, and MarketsandMarkets Analysis
19 © MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
RELATED REPORTS Report Title
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018
Description The choice of cells depends on various technical and economic aspects. E. coli, Bacillus subtitlus, and yeast are the most preferred bacteria as they are easier to grow, independent, and have metabolic capabilities. On the other hand, animal cells are fragile, larger than microorganisms and difficult to grow. Another important driver is the development of vaccines; influenza vaccines have been previously developed with the help of eggbased technology. However, due its labor-intensive approach, this has been replaced with cell culture. A growth in this market will subsequently drive the market for cell culture. http://www.marketsandmarkets.com/Market-Reports/cellculture-market-media-sera-reagents-559.html
Cell-based Assays Market by Product [Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services], Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018
The cell-based assay market is rapidly evolving with a large number of developments taking place to increase accuracy and speed, and reduce costs of drug. The global cell-based assay market is growing at a CAGR of 11.1% from 2013 to 2018 and poised to reach $14.8 billion by 2018. The global cell based assay market is segmented on the basis of products, applications, end users and geography. http://www.marketsandmarkets.com/Market-Reports/cellbased-assays-market-119917269.html
20 Š MarketsandMarkets
CELL LINE DEVELOPMENT MARKET – ANALYSIS & GLOBAL FORECAST TO 2019
BT 2750
Disclaimer: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customers’ internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation. MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications. MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets' research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users. All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner. No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission. Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.
For information regarding permission, contact: Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com
21 Š MarketsandMarkets